PubRank

Diego Vergani

Author PubWeight™ 111.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnosis and management of autoimmune hepatitis. Hepatology 2010 5.27
2 Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology 2012 2.81
3 Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology 2014 2.29
4 CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure. Cytometry A 2012 1.84
5 Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002 1.77
6 Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006 1.70
7 Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 2007 1.68
8 Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology 2006 1.64
9 Serial circulating markers of inflammation in biliary atresia--evolution of the post-operative inflammatory process. Hepatology 2007 1.61
10 Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004 1.54
11 Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology 2010 1.51
12 The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008 1.50
13 Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology 2013 1.47
14 Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant 2012 1.38
15 Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008 1.34
16 Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006 1.30
17 Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 2002 1.24
18 Autoimmune hepatitis: a comprehensive review. J Autoimmun 2012 1.16
19 The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007 1.16
20 The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008 1.15
21 Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011 1.14
22 PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010 1.13
23 Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005 1.13
24 A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010 1.10
25 Autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2009 1.09
26 The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology 2012 1.09
27 Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004 1.06
28 Liver transplantation in children. J Hepatol 2006 1.06
29 Biliary atresia. Semin Immunopathol 2009 1.05
30 Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2009 1.04
31 Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005 1.03
32 Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006 1.03
33 Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 2009 1.02
34 Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005 1.02
35 Autoimmune paediatric liver disease. World J Gastroenterol 2008 0.99
36 Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 2012 0.99
37 New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem 2009 0.99
38 Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis 2009 0.98
39 Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol 2011 0.98
40 Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 2005 0.96
41 The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010 0.96
42 Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int 2007 0.96
43 Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003 0.95
44 Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol 2009 0.94
45 Antimitochondrial and other autoantibodies. Clin Liver Dis 2003 0.94
46 Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun 2013 0.93
47 Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 2008 0.93
48 Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol 2010 0.93
49 Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy. J Virol 2010 0.93
50 Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology 2009 0.92
51 Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011 0.92
52 Autoimmune liver diseases in children - what is different from adulthood? Best Pract Res Clin Gastroenterol 2011 0.91
53 Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol 2012 0.91
54 Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 2007 0.90
55 Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin Infect Dis 2005 0.89
56 Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med 2010 0.88
57 Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl 2007 0.88
58 Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 2004 0.87
59 Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006 0.87
60 Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002 0.86
61 Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol 2004 0.86
62 Paralysed monocytes in acute on chronic liver disease. J Hepatol 2005 0.86
63 Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta 2007 0.86
64 Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol 2008 0.86
65 Autoimmune hepatitis in children. Clin Liver Dis 2002 0.86
66 Positive markers in AMA-negative PBC. Am J Gastroenterol 2003 0.85
67 Cytokine levels and profiles in children related to sickle cell disease and asthma status. J Interferon Cytokine Res 2011 0.85
68 Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun 2013 0.85
69 Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 2014 0.85
70 Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 2002 0.84
71 Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis 2004 0.84
72 High prevalence of food sensitisation in young children with liver disease: a clue to food allergy pathogenesis? Pediatr Allergy Immunol 2012 0.84
73 Human CD4+CD25(high)CD127 (low/neg) regulatory T cells. Methods Mol Biol 2012 0.84
74 Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology 2008 0.83
75 Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem 2004 0.83
76 Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int 2006 0.83
77 De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004 0.83
78 Unique features of primary sclerosing cholangitis in children. Curr Opin Gastroenterol 2010 0.82
79 Adaptive immunity in autoimmune hepatitis. Dig Dis 2010 0.82
80 Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease. IUBMB Life 2015 0.81
81 A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 2005 0.81
82 Viruses and autoantibodies in biliary atresia. Gastroenterology 2010 0.81
83 Liver transplantation and autoimmune liver diseases. Liver Transpl 2013 0.81
84 Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta 2012 0.81
85 Paediatric Autoimmune Liver Disease. Dig Dis 2015 0.80
86 T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun 2013 0.80
87 Unusual suspects in primary biliary cirrhosis. Hepatology 2004 0.80
88 Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis 2004 0.79
89 Treatment of hepatitis B virus in children: why, whom, how? Indian J Gastroenterol 2006 0.79
90 Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis 2010 0.79
91 Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2012 0.79
92 Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis. Liver Int 2011 0.79
93 Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives. J Pediatr Gastroenterol Nutr 2014 0.78
94 Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity 2002 0.78
95 Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions. J Pediatr Gastroenterol Nutr 2013 0.78
96 Serum autoantibodies: a road map for the clinical hepatologist. Autoimmunity 2008 0.78
97 "Neonatal hemochromatosis": a re-vision. Hepatology 2010 0.77
98 Paediatric autoimmune liver disease. Arch Dis Child 2013 0.77
99 Hepatitis B virus: something old, something new. J Pediatr Gastroenterol Nutr 2007 0.77
100 Regulatory T cells in autoimmune hepatitis. J Hepatol 2012 0.76
101 Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. Am J Surg Pathol 2012 0.76
102 Autoimmune hepatitis. Semin Liver Dis 2009 0.76
103 Budesonide for juvenile autoimmune hepatitis? Not yet. J Pediatr 2013 0.76
104 Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis. Clin Dev Immunol 2013 0.75
105 Autoimmune liver disease: news and perspectives. Transl Med UniSa 2011 0.75
106 LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation. Am J Gastroenterol 2008 0.75
107 Reply: To PMID 23787765. Hepatology 2015 0.75
108 The role of viral-specific immune responses on the outcome of chronic hepatitis B (HBV) infection in children: new insights into immunopathology. J Pediatr Gastroenterol Nutr 2007 0.75
109 Autoimmune liver disease. Indian J Pediatr 2002 0.75
110 Autoimmune liver disease in Asian children. Hepatol Int 2015 0.75
111 Chlamydia infection as risk factor for pediatric biliary tract disease. Eur J Gastroenterol Hepatol 2008 0.75
112 Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease. J Pediatr Gastroenterol Nutr 2017 0.75